PharmaGraphX

Log in Get Started

Fluvastatin

Lescol

HMG • CoA reductase inhibitor (statin)

Standard

Half-life

1-3 hours

Protein Binding

98%

Metabolized By

N/A

External

Drugs.com

Clinical alerts

Hepatotoxic

Monitor liver function

Mechanism of action

Competitively inhibits HMG-CoA reductase, reducing hepatic cholesterol synthesis

Recorded indications

From the drug index — may include conditions studied rather than approved indications

·Glioma
·Advanced Unresectable or Metastatic Breast Cancer
·Solid Tumors
·Ototoxicity
·Hypercholesterolaemia

Interactions

No curated interaction pairs are recorded for Fluvastatin. This is not a statement that none exist — check a full interaction reference before combining.

Common adverse effects

Dyspepsia
Headache
Myalgia
Insomnia

Food, alcohol & herbal

Alcohol · moderate

Alcohol increases hepatotoxicity risk

Pharmacokinetics

Half-life: 1-3 hours
Protein binding: 98%
Metabolised by: CYP2C9
Inhibits: CYP2C9

Pregnancy & lactation

Not recorded for Fluvastatin. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.

Sources

Assembled from: drug index, curated drug database.

Not a substitute for clinical judgement